Bicycle Therapeutics PLC
BCYC· Nasdaq
Released Mar 17, 2026, before the open
10-K filed Mar 17, 2026, 76 days after period end · 0001104659-26-028971
derived · Computed from the longer spans the company filed.
| Metric | Q4 2025dderived from reported figures | Q4 2024dderived from reported figures | Q4 2023dderived from reported figures | Q4 2022dderived from reported figures |
|---|---|---|---|---|
| Revenue | $47.96M | $3.71M | $5.33M | $3.19M |
| Net Income | -$20.15M |
Bicycle Therapeutics PLC · CIK 1761612 · Engraved from SEC EDGAR
| -$51.85M |
| -$49.10M |
| -$29.98M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.